4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001388492.1(HTT):​c.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA​(p.Gln30_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0070 ( 4 hom., cov: 0)
Exomes 𝑓: 0.0026 ( 41 hom. )

Consequence

HTT
NM_001388492.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.84

Publications

6 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3779750.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00701 (924/131880) while in subpopulation AMR AF = 0.00843 (113/13412). AF 95% confidence interval is 0.00754. There are 4 homozygotes in GnomAd4. There are 431 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA p.Gln30_Gln37dup disruptive_inframe_insertion Exon 1 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA p.Gln30_Gln37dup disruptive_inframe_insertion Exon 1 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA p.Gln30_Gln37dup disruptive_inframe_insertion Exon 1 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.00702
AC:
925
AN:
131782
Hom.:
4
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00613
Gnomad AMI
AF:
0.00750
Gnomad AMR
AF:
0.00851
Gnomad ASJ
AF:
0.00533
Gnomad EAS
AF:
0.00169
Gnomad SAS
AF:
0.00460
Gnomad FIN
AF:
0.00394
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00813
Gnomad OTH
AF:
0.00947
GnomAD4 exome
AF:
0.00259
AC:
3174
AN:
1225730
Hom.:
41
Cov.:
0
AF XY:
0.00271
AC XY:
1646
AN XY:
608074
show subpopulations
African (AFR)
AF:
0.00225
AC:
58
AN:
25808
American (AMR)
AF:
0.00383
AC:
116
AN:
30300
Ashkenazi Jewish (ASJ)
AF:
0.00290
AC:
66
AN:
22730
East Asian (EAS)
AF:
0.00175
AC:
51
AN:
29096
South Asian (SAS)
AF:
0.00312
AC:
225
AN:
72224
European-Finnish (FIN)
AF:
0.00455
AC:
148
AN:
32498
Middle Eastern (MID)
AF:
0.00423
AC:
16
AN:
3784
European-Non Finnish (NFE)
AF:
0.00239
AC:
2293
AN:
957466
Other (OTH)
AF:
0.00388
AC:
201
AN:
51824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
98
196
293
391
489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00701
AC:
924
AN:
131880
Hom.:
4
Cov.:
0
AF XY:
0.00680
AC XY:
431
AN XY:
63424
show subpopulations
African (AFR)
AF:
0.00611
AC:
217
AN:
35526
American (AMR)
AF:
0.00843
AC:
113
AN:
13412
Ashkenazi Jewish (ASJ)
AF:
0.00533
AC:
17
AN:
3190
East Asian (EAS)
AF:
0.00170
AC:
7
AN:
4124
South Asian (SAS)
AF:
0.00460
AC:
18
AN:
3910
European-Finnish (FIN)
AF:
0.00394
AC:
29
AN:
7368
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.00813
AC:
500
AN:
61482
Other (OTH)
AF:
0.00936
AC:
17
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
452

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Huntington disease Uncertain:1
Jan 22, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71180116; hg19: chr4-3076603; API